About the Authors
- Fabrice Crivello
-
* E-mail: fabrice.crivello@u-bordeaux2.fr
Affiliations Université de Bordeaux, GIN, UMR 5296, Bordeaux, France, CNRS, GIN, UMR 5296, Bordeaux, France, CEA, GIN, UMR 5296, Bordeaux, France
- Nathalie Tzourio-Mazoyer
-
Affiliations Université de Bordeaux, GIN, UMR 5296, Bordeaux, France, CNRS, GIN, UMR 5296, Bordeaux, France, CEA, GIN, UMR 5296, Bordeaux, France
- Christophe Tzourio
-
Affiliation INSERM, U708, Victor Segalen University, Bordeaux, France
- Bernard Mazoyer
-
Affiliations Université de Bordeaux, GIN, UMR 5296, Bordeaux, France, CNRS, GIN, UMR 5296, Bordeaux, France, CEA, GIN, UMR 5296, Bordeaux, France
Competing Interests
The Three-City Study is conducted under a partnership agreement between the Institut National de la Santé et de la Recherche Médicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: FC NTM CT BM. Performed the experiments: FC NTM CT BM. Analyzed the data: FC NTM CT BM. Contributed reagents/materials/analysis tools: FC NTM CT BM. Wrote the paper: FC NTM CT BM.